In the past 2 years, the US Food and Drug Administration (FDA) has approved 2 drugs for treating MASH, and bariatric surgical and endoscopic treatments are available as well
As GLP-1 uptake continues, weight management solutions, including structured weight management programs (SWMPs) like WeightWatchers (WW) and Noom, may still have a place in the shifting paradigm of obesity treatment
Polysaccharides-based nanoparticles as drug delivery systems
What took the world at storm was participants HADNT EVEN PLATEAUED IN WEIGHT LOSS at 48 weeks as the curves were still going down
[9] Retatrutide, being unlicensed in the UK, cannot currently be prescribed through standard NHS pathways
If you were on 2.4 mg semaglutide and experiencing diminishing returns, you might find that 1.7 mg after a reset produces stronger appetite suppression than 2.4 mg did before